ROLE OF PULMONARY-FUNCTION TESTS IN THE PREVENTION OF BLEOMYCIN PULMONARY TOXICITY DURING CHEMOTHERAPY FOR METASTATIC TESTICULAR TERATOMA

被引:24
作者
LUCRAFT, HH [1 ]
WILKINSON, PM [1 ]
STRETTON, TB [1 ]
READ, G [1 ]
机构
[1] MANCHESTER ROYAL INFIRM,MANCHESTER M13 9WL,LANCS,ENGLAND
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1982年 / 18卷 / 02期
关键词
D O I
10.1016/0277-5379(82)90056-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:133 / 139
页数:7
相关论文
共 18 条
[1]  
ADAMSON IYR, 1974, AM J PATHOL, V77, P185
[2]  
[Anonymous], 1970, Br Med J, V2, P643
[3]  
BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO
[4]  
2-N
[5]  
CARTER SK, 1978, CANCER CHEMOTH PHARM, V1, P123
[6]  
COMIS RL, 1979, CANCER RES, V39, P5076
[7]  
EINHORN L, 1976, CANCER, V37, P2414, DOI 10.1002/1097-0142(197605)37:5<2414::AID-CNCR2820370533>3.0.CO
[8]  
2-J
[9]   CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].
EINHORN, LH ;
DONOHUE, J .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298
[10]  
HAAS CD, 1976, CANCER, V38, P8, DOI 10.1002/1097-0142(197607)38:1<8::AID-CNCR2820380103>3.0.CO